カスタム抗体の世界市場レポート 2025年

カスタム抗体市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.3％で7億8,000万米ドルに成長します。予測期間中の成長は、標的免疫療法の採用増加、バイオ医薬品への投資増加、神経変性疾患の有病率増加、体外診断薬（IVD）アプリケーションの需要拡大、ヘルスケア支出の増加に起因すると考えられます。予測期間における主な動向としては、個別化医療の台頭、抗体工学の技術進歩、バイオテクノロジーと遺伝子工学の進歩、治療用途の拡大、抗体精製技術の革新などが挙げられます。

個別化医療に対する需要の高まりは、今後数年間のカスタム抗体市場の拡大を牽引すると予想されます。個別化医療は、個人の遺伝的体質、ライフスタイル、環境要因に基づいて治療や予防戦略を調整する医療アプローチです。個別化医療に対する需要の高まりは、ゲノミクスの進歩、バイオマーカーに基づく治療法の利用可能性の拡大、副作用を最小限に抑えつつ有効性を高めるカスタマイズされた治療オプションに対する消費者の嗜好の高まりによって後押しされています。カスタム抗体は、個別化治療戦略のための疾患検出、治療標的、バイオマーカー同定を改善する特異性の高い免疫試薬を提供することにより、個別化医療をサポートします。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、2023年に食品医薬品局（FDA）が希少疾患患者のために16の新しい個別化治療を承認し、2022年の6から増加したと報告しました。その結果、個別化医療に対する需要の高まりがカスタム抗体市場の成長を牽引しています。

カスタム抗体市場の主要企業は、抗体探索を強化し、特異性を向上させ、市場開拓プロセスを加速するために、人工知能のような先進技術の統合をますます進めています。人工知能は、抗原選択の精緻化、抗体-抗原相互作用の予測、機械学習を用いた候補スクリーニングの合理化によってカスタム抗体開発を支援し、最終的にはバイオ医薬品研究の迅速化とコスト効率の向上につながります。例えば、2024年10月、米国のバイオテクノロジー企業であるArchon Biosciences Inc.は、2,000万米ドルの資金を投じて、既存の抗体を治療用途にカスタマイズすることを可能にする、計算によって設計された抗体ケージの開発を開始しました。Archon社の独自技術は、抗体をケージ構造に組み立てることで、コア構造を変えることなく抗体の特性を変更することを可能にします。この技術革新は、治療標的に対する抗体の親和性を高めると同時に、標的外相互作用を低減し、有効性と安全性の両方を改善するように設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界カスタム抗体PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のカスタム抗体市場：成長率分析
• 世界のカスタム抗体市場の実績：規模と成長, 2019-2024
• 世界のカスタム抗体市場の予測：規模と成長, 2024-2029, 2034F
• 世界カスタム抗体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のカスタム抗体市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• ポリクローナル抗体
• 組み換え抗体
• その他のタイプ
• 世界のカスタム抗体市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体開発
• 抗体の生産と精製
• 抗体の断片化と標識
• 世界のカスタム抗体市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マウス
• うさぎ
• その他の情報源
• 世界のカスタム抗体市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 感染症
• 神経学
• 幹細胞
• 免疫学
• 心血管疾患
• その他の用途
• 世界のカスタム抗体市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 学術研究機関
• 契約調査機関
• 病院と診療所
• 世界のカスタム抗体市場モノクローナル抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• マウスモノクローナル抗体
• キメラモノクローナル抗体
• ヒト化モノクローナル抗体
• 完全ヒトモノクローナル抗体
• 世界のカスタム抗体市場ポリクローナル抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウサギポリクローナル抗体
• ヤギポリクローナル抗体
• 羊ポリクローナル抗体
• その他の動物由来ポリクローナル抗体
• 世界のカスタム抗体市場組換え抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単鎖可変フラグメント（scFv）
• ナノボディ
• 二重特異性抗体
• 抗体断片
• 世界のカスタム抗体市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アプタマー
• ナノボディ（ラクダ科動物の抗体）
• ハイブリドーマ

第7章 地域別・国別分析

• 世界のカスタム抗体市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のカスタム抗体市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• カスタム抗体市場：競合情勢
• カスタム抗体市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• GenScript Biotech Corporation
• BioLegend Inc.
• Abcam plc
• Cusabio Biotech Co. Ltd.
• OriGene Technologies Inc.
• Cell Signaling Technology Inc.
• Abgent Inc.
• ProSci Incorporated
• Santa Cruz Biotechnology Inc.
• Rockland Immunochemicals Inc.
• Creative Biolabs Inc.
• Novus Biologicals LLC
• Creative Diagnostics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• カスタム抗体市場2029：新たな機会を提供する国
• カスタム抗体市場2029：新たな機会を提供するセグメント
• カスタム抗体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A custom antibody is a laboratory-engineered antibody specifically developed to target a particular antigen of interest. These antibodies are designed for research, diagnostic, or therapeutic purposes, catering to the unique requirements of scientists and healthcare professionals. Custom antibodies play a crucial role in biomedical research, diagnostics, and drug development, enabling precise detection and targeting of biomolecules.

The primary types of custom antibodies include monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other variants. Monoclonal antibodies are lab-created molecules that precisely target a specific antigen, mimicking the immune system's natural pathogen-fighting mechanism. Services in this market encompass antibody development, production and purification, as well as fragmentation and labeling. The sources of custom antibodies include mice, rabbits, and other organisms. These antibodies are utilized in various fields such as oncology, infectious diseases, neurology, stem cell research, immunology, and cardiovascular diseases. The key end users of custom antibodies include pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, and hospitals and clinics.

The custom antibody market research report is one of a series of new reports from The Business Research Company that provides custom antibody market statistics, including the custom antibody industry global market size, regional shares, competitors with the custom antibody market share, detailed custom antibody market segments, market trends, and opportunities, and any further data you may need to thrive in the custom antibody industry. This custom antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The custom antibody market size has grown rapidly in recent years. It will grow from $0.42 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth during the historic period can be attributed to the rising demand for custom antibodies, the expanding use of precision medicine, the increasing prevalence of chronic diseases and cancer, the surge in research and development activities, and the growing number of clinical trials.

The custom antibody market size is expected to see rapid growth in the next few years. It will grow to $0.78 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth during the forecast period can be attributed to the increasing adoption of targeted immunotherapy, rising investment in biopharmaceuticals, the growing prevalence of neurodegenerative diseases, the expanding demand for in vitro diagnostics (IVD) applications, and rising healthcare expenditures. Key trends in the forecast period include the rise of personalized medicine, technological advancements in antibody engineering, progress in biotechnology and genetic engineering, expanding therapeutic applications, and innovations in antibody purification techniques.

The increasing demand for personalized medicine is anticipated to drive the expansion of the custom antibody market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies based on an individual's genetic makeup, lifestyle, and environmental factors. The rising demand for personalized medicine is fueled by advancements in genomics, the growing availability of biomarker-based therapies, and a heightened consumer preference for customized treatment options that enhance efficacy while minimizing adverse effects. Custom antibodies support personalized medicine by providing highly specific immune reagents that improve disease detection, therapeutic targeting, and biomarker identification for individualized treatment strategies. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022. As a result, the increasing demand for personalized medicine is driving the growth of the custom antibody market.

Leading companies in the custom antibody market are increasingly integrating advanced technologies such as artificial intelligence to enhance antibody discovery, improve specificity, and accelerate development processes. Artificial intelligence aids custom antibody development by refining antigen selection, predicting antibody-antigen interactions, and streamlining candidate screening using machine learning, ultimately leading to faster and more cost-effective biopharmaceutical research. For instance, in October 2024, Archon Biosciences Inc., a US-based biotechnology company, launched with $20 million in funding to develop computationally designed antibody cages that enable the customization of existing antibodies for therapeutic applications. Archon's proprietary technology assembles antibodies into cage structures, allowing modifications to their properties without altering their core structures. This innovation is designed to enhance antibody affinity for therapeutic targets while reducing off-target interactions, improving both efficacy and safety.

In September 2024, Leinco Technologies Inc., a US-based biotechnology company, acquired QED Biosciences Inc. for an undisclosed amount. This acquisition is intended to support Leinco Technologies' strategic growth by expanding its market presence and strengthening its offerings in the life sciences and IVD raw material sectors. QED Bioscience Inc., also a US-based biotechnology company, specializes in the design and production of custom antibodies.

Major players in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS.

North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in custom antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the custom antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The custom antibody market consists of revenues earned by entities by providing services such as antibody production, antibody purification, and conjugation. The market value includes the value of related goods sold by the service provider or included within the service offering. The custom antibody market also consists of sales of products including antibody fragments, conjugated antibodies, and secondary antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Custom Antibody Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on custom antibody market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for custom antibody ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The custom antibody market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies; Other Types
• 2) By Service: Antibody Development; Antibody Production And Purification; Antibody Fragmentation And Labeling
• 3) By Source: Mice; Rabbit; Other Sources
• 4) By Application: Oncology; Infectious Diseases; Neurology; Stem Cells; Immunology; Cardiovascular Diseases; Other Applications
• 5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organization; Hospitals And Clinics
• Subsegments:
• 1) By Monoclonal Antibodies: Murine Monoclonal Antibodies; Chimeric Monoclonal Antibodies; Humanized Monoclonal Antibodies; Fully Human Monoclonal Antibodies
• 2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies; Goat Polyclonal Antibodies; Sheep Polyclonal Antibodies; Other Animal-Derived Polyclonal Antibodies
• 3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv); Nanobodies; Bispecific Antibodies; Antibody Fragments
• 4) By Other Types: Aptamers; Nanobodies (Camelid Antibodies); Hybridomas
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Lonza Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Custom Antibody Market Characteristics

3. Custom Antibody Market Trends And Strategies

4. Custom Antibody Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Custom Antibody Growth Analysis And Strategic Analysis Framework

• 5.1. Global Custom Antibody PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Custom Antibody Market Growth Rate Analysis
• 5.4. Global Custom Antibody Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Custom Antibody Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Custom Antibody Total Addressable Market (TAM)

6. Custom Antibody Market Segmentation

• 6.1. Global Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Other Types
• 6.2. Global Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Development
• Antibody Production And Purification
• Antibody Fragmentation And Labeling
• 6.3. Global Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mice
• Rabbit
• Other Sources
• 6.4. Global Custom Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Infectious Diseases
• Neurology
• Stem Cells
• Immunology
• Cardiovascular Diseases
• Other Applications
• 6.5. Global Custom Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Contract Research Organization
• Hospitals And Clinics
• 6.6. Global Custom Antibody Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Murine Monoclonal Antibodies
• Chimeric Monoclonal Antibodies
• Humanized Monoclonal Antibodies
• Fully Human Monoclonal Antibodies
• 6.7. Global Custom Antibody Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rabbit Polyclonal Antibodies
• Goat Polyclonal Antibodies
• Sheep Polyclonal Antibodies
• Other Animal-Derived Polyclonal Antibodies
• 6.8. Global Custom Antibody Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Chain Variable Fragment (scFv)
• Nanobodies
• Bispecific Antibodies
• Antibody Fragments
• 6.9. Global Custom Antibody Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aptamers
• Nanobodies (Camelid Antibodies)
• Hybridomas

7. Custom Antibody Market Regional And Country Analysis

• 7.1. Global Custom Antibody Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Custom Antibody Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Custom Antibody Market

• 8.1. Asia-Pacific Custom Antibody Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Custom Antibody Market

• 9.1. China Custom Antibody Market Overview
• 9.2. China Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Custom Antibody Market

• 10.1. India Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Custom Antibody Market

• 11.1. Japan Custom Antibody Market Overview
• 11.2. Japan Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Custom Antibody Market

• 12.1. Australia Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Custom Antibody Market

• 13.1. Indonesia Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Custom Antibody Market

• 14.1. South Korea Custom Antibody Market Overview
• 14.2. South Korea Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Custom Antibody Market

• 15.1. Western Europe Custom Antibody Market Overview
• 15.2. Western Europe Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Custom Antibody Market

• 16.1. UK Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Custom Antibody Market

• 17.1. Germany Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Custom Antibody Market

• 18.1. France Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Custom Antibody Market

• 19.1. Italy Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Custom Antibody Market

• 20.1. Spain Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Custom Antibody Market

• 21.1. Eastern Europe Custom Antibody Market Overview
• 21.2. Eastern Europe Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Custom Antibody Market

• 22.1. Russia Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Custom Antibody Market

• 23.1. North America Custom Antibody Market Overview
• 23.2. North America Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Custom Antibody Market

• 24.1. USA Custom Antibody Market Overview
• 24.2. USA Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Custom Antibody Market

• 25.1. Canada Custom Antibody Market Overview
• 25.2. Canada Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Custom Antibody Market

• 26.1. South America Custom Antibody Market Overview
• 26.2. South America Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Custom Antibody Market

• 27.1. Brazil Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Custom Antibody Market

• 28.1. Middle East Custom Antibody Market Overview
• 28.2. Middle East Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Custom Antibody Market

• 29.1. Africa Custom Antibody Market Overview
• 29.2. Africa Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Custom Antibody Market Competitive Landscape And Company Profiles

• 30.1. Custom Antibody Market Competitive Landscape
• 30.2. Custom Antibody Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Custom Antibody Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Bio-Techne Corporation
• 31.3. GenScript Biotech Corporation
• 31.4. BioLegend Inc.
• 31.5. Abcam plc
• 31.6. Cusabio Biotech Co. Ltd.
• 31.7. OriGene Technologies Inc.
• 31.8. Cell Signaling Technology Inc.
• 31.9. Abgent Inc.
• 31.10. ProSci Incorporated
• 31.11. Santa Cruz Biotechnology Inc.
• 31.12. Rockland Immunochemicals Inc.
• 31.13. Creative Biolabs Inc.
• 31.14. Novus Biologicals LLC
• 31.15. Creative Diagnostics Inc.

32. Global Custom Antibody Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Custom Antibody Market

34. Recent Developments In The Custom Antibody Market

35. Custom Antibody Market High Potential Countries, Segments and Strategies

• 35.1 Custom Antibody Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Custom Antibody Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Custom Antibody Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer